Search Results
Dec 18, 2025, 06:45 ET Canada Nickel Announces Initial Resources at Midlothian and Bannockburn Projects
3.4Jun-250.41
More news about: Canada Nickel Company Inc.
Dec 17, 2025, 14:15 ET O segredo da musa! Sabrina Sato revela a sua rotina de cuidados com a pele para a temporada de verão e Carnaval
Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013 Jun;39(6):915-22.7. Machado Filho CDS, et al. PolyLlactic acid: a biostimulating agent. Surg Cosmet Dermatol 2013;5(4):345-50. 8.
More news about: Galderma
Dec 17, 2025, 12:30 ET Centric Software Accelerates Retail Performance with AI-Powered Solutions at NRF 2026
AI-powered solutions:"The greatest benefit is having complete visibility of all information that's instantly shared with everyone involved," says Jun Kato, General Manager for DX Promotion at Onward Holdings, Co, Ltd."Centric Software felt like the right fit from day one: they have a deep understanding
More news about: Centric Software
Dec 15, 2025, 17:04 ET SEG Solar Mulai Bangun Pabrik Ingot dan Wafer Berkapasitas 3 GW di Indonesia
berkapasitas 3 GW, SEG akan membangun sistem rantai produksi secara menyeluruh—mulai dari ingot dan wafer, sel surya, hingga panel surya.Jun Zhuge, Founder & Chief Executive Officer, PT SEG Solar Manufaktur, berkata, "Pengembangan kapasitas produksi ingot dan wafer
More news about: SEG Solar
Dec 15, 2025, 17:00 ET Enginprime Medical Inc Announces First-in-Human Study of Its Leading OpusOne™ pVAD
OpusOneTM's optimization of access and positioning options increases procedural safety."Co-investigator of the study, Jun Jiang, MD, PhD, Executive Associate Director of the Department of Cardiology at SAHZU added, "We are pleased to perform the first procedure
More news about: Enginprime Medical Inc; Voyagers Capital
Dec 15, 2025, 09:00 ET SEG Solar Commences Build-Out of 3GW Ingot and Wafer Production Facility in Indonesia
ingot and wafer facility, SEG will establish an end-to-end manufacturing chain—from ingots and wafers to solar cells and finished modules. Mr. Jun Zhuge, Founder and Chief Executive Officer of PT SEG Solar Manufaktur, stated: "Developing upstream ingot and wafer capacity is essential to completing
More news about: SEG Solar
Dec 15, 2025, 09:00 ET SEG Solar khởi công xây dựng cơ sở sản xuất thanh năng lượng mặt trời silicon và tấm wafer công suất 3GW tại Indonesia
lập một chuỗi sản xuất khép kín từ thanh năng lượng mặt trời silicon và tấm wafer đến cell pin năng lượng mặt trời và mô-đun hoàn chỉnh.Ông Jun Zhuge, Nhà sáng lập kiêm Giám đốc điều hành của PT SEG Solar Manufaktur, cho biết:"Việc phát triển năng lực sản xuất thanh năng lượng mặt trời
More news about: SEG Solar
Dec 15, 2025, 05:14 ET Breast Pump Market Set to Grow at an Impressive CAGR of 8.75% Through 2035 | 8.12 USD Billion | Vantage Market Research
optimization.Mar 2025: Partnerships between pump manufacturers and digital lactation platforms for integrated breastfeeding analytics.Jun 2025: Rollout of next-gen wearable pumps featuring ultra-quiet motors and all-in-bra concealed designs.Aug 2025: Expansion of employer-sponsored
More news about: Vantage Market Research
Dec 12, 2025, 13:23 ET Efeitos imediatos: descobrimos os tratamentos que vão recuperar o glow da sua pele a tempo de aproveitar as festas de final de ano
1:S10-S18.5. Kim J, et al. Arch Aesthetic Plast Surg. 2014;20(2):97-1036. Weiss RA, et al. Dermatol Surg. 2016 Jun;42(6):699-7097. Di Gregorio C, et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690.8. Talarico S, et al. Dermatol
More news about: Galderma
Dec 11, 2025, 10:30 ET Rapafusyn Founder Dr. Jun O. Liu Elected as National Academy of Inventors Fellow
Pharmaceuticals, a biotechnology company advancing next-generation molecular glue therapeutics for hard-to-drug targets, today announced that its founder, Dr. Jun O. Liu of the Johns Hopkins University School of Medicine, has been elected a Fellow of the National Academy of Inventors (NAI), the organization's highest
More news about: Rapafusyn Pharmaceuticals
Dec 11, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Cepton, Inc. and Certain Officers - CPTN
Cepton at more than double" the Koito Acquisition. The Amended Complaint further alleges that Cepton's Chief Executive Officer Defendant Jun Pei was subject to conflicts in his negotiations with Koito and encouraged the Board to recommend accepting the Koito Acquisition so as to protect his
More news about: Pomerantz LLP
Dec 10, 2025, 22:24 ET ODE TO NOBLE LABORERS
the mainstay of the great task of our nation's rejuvenation," Zhu said.Intelligent evolution At Baosteel's hot rolling mill, Wang Jun, a skilled expert in his prime, is synonymous with "smart transformation".Progressing from a technical school graduate to a "worker-inventor"
More news about: China Daily
Dec 09, 2025, 11:03 ET Pew Funds 7 New Biomedical Research Collaborations
Suckjoon Jun, Ph.D., 2013 Pew biomedical scholar, University of California San DiegoRust and Jun will explore how cyanobacteria regulate growth and allocate cellular resources in fluctuating environments.
More news about: The Pew Charitable Trusts
Dec 09, 2025, 11:03 ET Pew fomenta 7 novas colaborações em pesquisa biomédica
Suckjoon Jun, Ph.D., da classe de 2013 do Pew biomedical scholar, University of California San DiegoRust e Jun explorarão como as cianobactérias regulam seu crescimento e alocam recursos celulares em
More news about: The Pew Charitable Trusts
Dec 09, 2025, 11:03 ET Pew financia 7 nuevas colaboraciones en investigación biomédica
Suckjoon Jun, Ph.D., académico del programa Pew en biomedicina del año 2013, Universidad de California San DiegoRust y Jun estudiarán cómo las cianobacterias regulan el crecimiento y distribuyen los recursos
More news about: The Pew Charitable Trusts
Dec 09, 2025, 07:30 ET Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
doi:10.1016/S0140-6736(21)00224-5Hanel W, Epperla N. Emerging therapies in mantle cell lymphoma. J Hematol Oncol. 2020;13(1):79. Published 2020 Jun 17. doi:10.1186/s13045-020-00914-1Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell
More news about: Eli Lilly and Company
Dec 09, 2025, 01:54 ET GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy
Biopharma Contacts (Media)Sohee [email protected] Jun[email protected] Na
More news about: GC Genome
Dec 08, 2025, 06:30 ET 51Talk Online Education Group Announces Third Quarter 2025 Results
Jun. 30,
More news about: 51Talk Online Education Group
Dec 08, 2025, 01:36 ET GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'
Biopharma Contacts (Media)Sohee [email protected] Jun[email protected] Na
More news about: GC Biopharma
Dec 07, 2025, 16:30 ET Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)
doi:10.1016/S0140-6736(21)00224-5Hanel W, Epperla N. Emerging therapies in mantle cell lymphoma. J Hematol Oncol. 2020;13(1):79. Published 2020 Jun 17. doi:10.1186/s13045-020-00914-1Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell
More news about: Eli Lilly and Company
Dec 04, 2025, 08:32 ET Pusan National University Researchers Identify the Brain Enzyme That Drives Nicotine Addiction and Smoking Dependence
of the caudate and putamen region of brain, initiating a surge in intracellular calcium. This rise in calcium led to activation of phosphorylated c-Jun N-terminal kinase (pJNK), a signaling molecule known to respond to cellular stress and drug exposure. Once activated, JNK further interacted with the
More news about: Pusan National University
Dec 03, 2025, 21:00 ET 미국임상종양학회, 'ASCO 브레이크스루 2026' 개최 일정 발표
추아(Melvin Chua) 박사, 차기 의장인 마닐라센트럴대학교 로젤 드 구즈만(Roselle De Guzman) 박사, 싱가포르 국립암센터 및 싱가포르종양학회 소속 아일린 푼(Eileen Poon) 박사, 중산대학암센터 및 ASCO 아시아•태평양 지역위원회 대표 마준(Ma Jun) 박사로 구성됐다. 윤옌 박사는 "ASCO 브레이크스루는 학술 연구와 임상 현장을 연결하는 중요한 플랫폼"이라며 "혁신적인 데이터를 국제 무대에서 공유하고, 이를 임상 적용으로 이어갈 수 있는 기회의 장이 될 것"이라고 말했다.ASCO는 인공지능(AI)과
More news about: The American Society of Clinical Oncology
Dec 03, 2025, 21:00 ET American Society of Clinical Oncology (ASCO) announces dates for 2026 ASCO Breakthrough and begins accepting submissions for novel oncology research
Roselle De Guzman, Manila Central University; Dr. Eileen Poon, National Cancer Centre Singapore and the Singapore Society of Oncology, as well as Dr. Jun Ma, Sun Yat-sen University Cancer Centre and ASCO Asia Pacific Regional Council Representative."ASCO Breakthrough is a powerful catalyst where
More news about: The American Society of Clinical Oncology
Dec 03, 2025, 16:56 ET Tendências para 2026: esses são os procedimentos estéticos que estarão em alta para o ano que vem
France9. Markowitz O, et al. Galderma R&D Poster Presentation, IMCAS 2025.10. Weiss RA, et al. Dermatol Surg. 2016 Jun;42(6):699-709 11. Di Gregorio, C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 12. Talarico S, et al. Dermatol
More news about: Galderma
Dec 03, 2025, 12:59 ET U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor
doi:10.1016/S0140-6736(21)00224-5Hanel W, Epperla N. Emerging therapies in mantle cell lymphoma. J Hematol Oncol. 2020;13(1):79. Published 2020 Jun 17. doi:10.1186/s13045-020-00914-1Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell
More news about: Eli Lilly and Company